Mednax Inc (MD)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | 3.14 | — | — | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 0.00 | 3.14 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= — + — – —
= 0.00
The cash conversion cycle for Mednax Inc has been consistently efficient, with a cycle of 0.00 days for the years 2020, 2021, and 2022. This indicates that the company is able to quickly convert its investments in inventory and accounts receivable into cash.
In 2023, there was a slight increase in the cash conversion cycle to 3.14 days, suggesting a temporary delay in the conversion process. This may be due to changes in the company's operating cycle or cash management practices.
However, by 2024, the company was able to revert back to its efficient cash conversion cycle of 0.00 days. Overall, the trend indicates good management of working capital and efficient utilization of resources to generate cash inflows.
Peer comparison
Dec 31, 2024